<DOC>
<DOCNO>
EP-0005956
</DOCNO>
<TEXT>
<DATE>
19791212
</DATE>
<IPC-CLASSIFICATIONS>
A61K-35/66 A61P-31/00 A61K-35/74 C12P-1/06 C07G-11/00 C07K-4/04 C07K-4/00 A61K-38/00 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
a-38533 antibiotics, their preparation, formulations containing them, and micro-organism employed in their production.
</TITLE>
<APPLICANT>
lilly co elius <sep>eli lilly and company<sep>eli lilly and company 307, east mccarty street indianapolis indiana 46285us<sep>
</APPLICANT>
<INVENTOR>
godfrey otis websterus<sep>johnson ronald doyleus<sep>kastner ralph emilus<sep>godfrey, otis webster<sep>johnson, ronald doyle<sep>kastner, ralph emil<sep>godfrey, otis webster222, serenity waygreenwood indiana 46142us<sep>johnson, ronald doyle6106 n. evanstonindianapolis indiana 46220us<sep>kastner, ralph emil243, webb driveindianapolis indiana 46227us<sep>
</INVENTOR>
<ABSTRACT>
novel peptide antibiotics, a-38533 factors a₁, a₂, b and  c, effective against pseudomonas species are described.  also  described are a process for preparation of the antibiotic  factors by submerged aerobic fementation of a culture  containing streptomyces species nrrl 11298, a synthetic  culture medium containing that organism and the organism  per se.  
</ABSTRACT>
</TEXT>
</DOC>
